Download PDF
Thromb Haemost 1999; 81(03): 462
DOI: 10.1055/s-0037-1614495
Scientific and Standardization Committee Communications
Schattauer GmbH

Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates

Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Gilbert C. White
,
Donna DiMichele
,
Koen Mertens
,
Claude Negrier
,
Ian R. Peake
,
Christopher Prowse
,
Ranier Schwaab
,
Akira Yoshioka
,
Jørgen Ingerslev Chairman
Further Information

Publication History

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Rosendaal FR. et al. A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group. Blood 1993; 81: 2180-6.
    PubMedGoogle Scholar
  • 2 Peerlinck K. et al. Factor VIII inhibitors in previously treated haemophilia A patients with a double viruS-inactivated plasma derived factor VIII concentrate. Thromb Haemost 1997; 77: 80-6.
    Article in Thieme ConnectPubMedGoogle Scholar